Merck & Co Inc
NYSE: MRK
$96.31
-$2.05 (-2.1%)
Closing Price on November 15, 2024
MRK Articles
Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week, including Apple, Exxon and Pfizer.
Published:
Last Updated:
The July 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
24/7 Wall St. screened the Merrill Lynch US 1 list looking for the stocks paying the highest dividends, as rates are going nowhere this year or next, and the total return component of dividend-paying...
Published:
Last Updated:
The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were increased.
Published:
Last Updated:
President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the effort being blocked on free speech concerns.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras, Starbucks, Symantec and Tesla.
Published:
Last Updated:
The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Top stock stories for the week of June 14, 2019 from earnings, mergers, analyst calls and more.
Published:
Last Updated:
Merck is set to host its Investor Day on June 20. Investors will have a high bar of expectations because so much of Merck's story is known.
Published:
Last Updated:
The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday included Alarm.com, Exxon Mobil, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy's and Zoom Video Communications.
Published:
Last Updated:
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included American Water Works, Arconic, Cree, Dell Technologies, Humana, Merck, Qualcomm, Square, Tesla and Zynga.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Apple, Pfizer and other Dow companies scheduled to report their quarterly results this week.
Published:
Last Updated: